{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:05:30Z","timestamp":1786770330254,"version":"build-2736575974"},"reference-count":56,"publisher":"Society for Neuroscience","issue":"9","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":184,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neurosci."],"published-print":{"date-parts":[[2000,5,1]]},"abstract":"<jats:p>Vascularized whole organ discordant xenografts placed in the periphery are rejected by a rapid \u201chyperacute\u201d process that involves preformed antibody binding to the xeno-antigens on the donor endothelial cells with complement activation. In the CNS, xenografts are classically thought to be rejected more slowly by a T-cell-dependent process. We now report that xenografts of embryonic porcine ventral mesencephalic tissue in the 6-hydroxydopamine-lesioned, nonimmunosuppressed rat induce both a humoral and a cell-mediated response. Over the first 10 d after implantation, the xenografts matured with identifiable TH neurons and pig-specific neurofilament fibers extending along host white matter tracts. During this period of time, IgM and complement binding were observed within the graft, as well as a CD8 cellular infiltrate, leading to rejection of the transplant over the next 25 d. These intracerebral xenografts were not associated with an early systemic antibody response. A role for complement in this rejection process was further investigated using cobra venom factor (CVF), which systemically depleted the rats of complement for 7 d. CVF treatment, when given in the period immediately before and after grafting, delayed but did not prevent the cellular immune response induced by the graft, demonstrating that xenografted neural tissue can activate the humoral arm of the rejection process, in particular the complement cascade. This suggests that interventions targeting this aspect of the immune rejection process may be of great importance for the future development of xenotransplantation for neurodegenerative conditions.<\/jats:p>","DOI":"10.1523\/jneurosci.20-09-03415.2000","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T02:15:51Z","timestamp":1522894551000},"page":"3415-3424","source":"Crossref","is-referenced-by-count":60,"title":["A Role for Complement in the Rejection of Porcine Ventral Mesencephalic Xenografts in a Rat Model of Parkinson's Disease"],"prefix":"10.1523","volume":"20","author":[{"given":"Roger A.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Mclaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"393","published-online":{"date-parts":[[2000,5,1]]},"reference":[{"key":"2023041302445973000_20.9.3415.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.433"},{"key":"2023041302445973000_20.9.3415.2","first-page":"229","article-title":"Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.","volume":"65","author":"Arvieux","year":"1988","journal-title":"Immunology"},{"key":"2023041302445973000_20.9.3415.3","doi-asserted-by":"publisher","DOI":"10.1016\/0963-6897(95)90032-2"},{"key":"2023041302445973000_20.9.3415.4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/096368979900800605","article-title":"Fetal porcine dopaminergic cell survival in vitro and its relationship to embryonic age.","volume":"8","author":"Barker","year":"1999","journal-title":"Cell Transplant"},{"key":"2023041302445973000_20.9.3415.5","doi-asserted-by":"crossref","unstructured":"Barker RA, Kendall AL, Widner H, and the \u201cNeural Tissue Xenografting Project\u201d (2000) Neural tissue xenotransplantation: what is needed prior to clinical trials? Cell Transplant, in press.","DOI":"10.1177\/096368970000900209"},{"key":"2023041302445973000_20.9.3415.6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00237035","article-title":"Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons.","volume":"60","author":"Brundin","year":"1985","journal-title":"Exp Brain Res"},{"key":"2023041302445973000_20.9.3415.7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00248542","article-title":"Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier.","volume":"75","author":"Brundin","year":"1989","journal-title":"Exp Brain Res"},{"key":"2023041302445973000_20.9.3415.8","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-350"},{"key":"2023041302445973000_20.9.3415.9","first-page":"1056","article-title":"Xenotransplantation of transgenic fetal pig dopamine neurons to rats and systemic prevention of host complement-mediated cell lysis.","volume":"421.9","author":"Deacon","year":"1998","journal-title":"Soc Neurosci Abstr"},{"key":"2023041302445973000_20.9.3415.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5247.348"},{"key":"2023041302445973000_20.9.3415.11","first-page":"1184","article-title":"Study of concordant xenografted islets of Langerhans rejection: humoral or cellular mechanism?","volume":"26","author":"Deng","year":"1994","journal-title":"Transplant Proc"},{"key":"2023041302445973000_20.9.3415.12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00242009","article-title":"Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats.","volume":"104","author":"Duan","year":"1995","journal-title":"Exp Brain Res"},{"key":"2023041302445973000_20.9.3415.13","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01409-8"},{"key":"2023041302445973000_20.9.3415.14","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(84)90013-0"},{"key":"2023041302445973000_20.9.3415.15","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(91)90011-H"},{"key":"2023041302445973000_20.9.3415.16","first-page":"A405","article-title":"Double-blind controlled trial of human embryonic dopaminergic tissue transplants in advanced Parkinson's disease: clinical outcomes.","volume":"52[Suppl 2]","author":"Fahn","year":"1999","journal-title":"Neurology"},{"key":"2023041302445973000_20.9.3415.17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00271854","article-title":"Xenografting of fetal mouse hippocampal tissue to the brain of adult rats: effects of Cyclosporin A treatment.","volume":"70","author":"Finsen","year":"1988","journal-title":"Exp Brain Res"},{"key":"2023041302445973000_20.9.3415.18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0079-6123(08)62597-2","article-title":"Immune reactions against intracerebral murine xenografts of fetal hippocampal tissue and cultured cortical astrocytes in the adult rat.","volume":"82","author":"Finsen","year":"1990","journal-title":"Prog Brain Res"},{"key":"2023041302445973000_20.9.3415.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.23.11153"},{"key":"2023041302445973000_20.9.3415.20","unstructured":"Harrison RA Lachman PJ (1986) Complement technology. in Handbook of experimental immunology, Vol 1, ed Weir DM (Blackwell Science, Oxford), p 19."},{"key":"2023041302445973000_20.9.3415.21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00001756-199011000-00019","article-title":"Human neural graft function in rats treated with anti-interleukin II receptor antibody.","volume":"1","author":"Honey","year":"1990","journal-title":"NeuroReport"},{"key":"2023041302445973000_20.9.3415.22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(85)80122-1","article-title":"Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain.","volume":"54","author":"Inoue","year":"1985","journal-title":"Neurosci Lett"},{"key":"2023041302445973000_20.9.3415.23","doi-asserted-by":"publisher","DOI":"10.1038\/nm0997-964"},{"key":"2023041302445973000_20.9.3415.24","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90378-8"},{"key":"2023041302445973000_20.9.3415.25","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6685"},{"key":"2023041302445973000_20.9.3415.26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.870130303","article-title":"Neuropathology of fetal nigral grafts in patients with Parkinson's disease.","volume":"13","author":"Kordower","year":"1998","journal-title":"Mov Disord"},{"key":"2023041302445973000_20.9.3415.27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00007890-199910270-00016","article-title":"The role of immunoglobulins in the rejection of discordant neural xenografts.","volume":"27","author":"Larsson","year":"1999","journal-title":"Transplantation"},{"key":"2023041302445973000_20.9.3415.28","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1097\/00001756-199709290-00036","article-title":"Neural transplantation: a hope for patients with Parkinson's disease.","volume":"8","author":"Lindvall","year":"1997","journal-title":"NeuroReport"},{"key":"2023041302445973000_20.9.3415.29","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90071-I"},{"key":"2023041302445973000_20.9.3415.30","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199604150-00019"},{"key":"2023041302445973000_20.9.3415.31","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1212\/WNL.44.10.1777","article-title":"Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?","volume":"44","author":"Martin","year":"1994","journal-title":"Neurology"},{"key":"2023041302445973000_20.9.3415.32","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(86)90292-7"},{"key":"2023041302445973000_20.9.3415.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(96)00472-1"},{"key":"2023041302445973000_20.9.3415.34","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)20028-F"},{"key":"2023041302445973000_20.9.3415.35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00742.x"},{"key":"2023041302445973000_20.9.3415.36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19970601)48:5<385::AID-JNR1>3.0.CO;2-A"},{"key":"2023041302445973000_20.9.3415.37","first-page":"177","article-title":"Immunohistochemical analysis on the rejection of xenogeneic brain grafts.","volume":"11","author":"Okura","year":"1997","journal-title":"Restor Neurol Neurosci"},{"key":"2023041302445973000_20.9.3415.38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1999.00666.x"},{"key":"2023041302445973000_20.9.3415.39","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90338-7"},{"key":"2023041302445973000_20.9.3415.40","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00626-G"},{"key":"2023041302445973000_20.9.3415.41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00241113","article-title":"Prevention of mouse-rat brain xenograft rejection by a combination of cyclosporin A, prednisolone and azathioprine.","volume":"106","author":"Pedersen","year":"1995","journal-title":"Exp Brain Res"},{"key":"2023041302445973000_20.9.3415.42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0079-6123(08)62598-4","article-title":"MHC antigen expression in spontaneous and induced rejection of neural xenografts.","volume":"82","author":"Pollack","year":"1990","journal-title":"Prog Brain Res"},{"key":"2023041302445973000_20.9.3415.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(96)80041-4"},{"key":"2023041302445973000_20.9.3415.44","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199505000-00018"},{"key":"2023041302445973000_20.9.3415.45","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91750-U"},{"key":"2023041302445973000_20.9.3415.46","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(91)90159-R"},{"key":"2023041302445973000_20.9.3415.47","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7181"},{"key":"2023041302445973000_20.9.3415.48","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(70)90187-3"},{"key":"2023041302445973000_20.9.3415.49","unstructured":"Vogel C (1992) Cobra venom factor. in Encylopaedia of immunology, eds Roitt I Delves P (Academic, London), p 363."},{"key":"2023041302445973000_20.9.3415.50","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509270-00013"},{"key":"2023041302445973000_20.9.3415.51","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5431.1221"},{"key":"2023041302445973000_20.9.3415.52","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420115"},{"key":"2023041302445973000_20.9.3415.53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/cne.903230403","article-title":"Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.","volume":"22","author":"Wictorin","year":"1992","journal-title":"J Comp Neurol"},{"key":"2023041302445973000_20.9.3415.54","doi-asserted-by":"crossref","unstructured":"Widner H (1998) The Lund transplant program for Parkinson's disease and patients with MPTP-induced parkinsonism. in Cell transplantation for neurological disorders: toward reconstruction of the human central nervous system, eds Freeman TB Widner H (Humana, Totowa, NJ), pp 1\u201317.","DOI":"10.1007\/978-1-59259-476-4_1"},{"key":"2023041302445973000_20.9.3415.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)83014-4"},{"key":"2023041302445973000_20.9.3415.56","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90313-C"}],"container-title":["The Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1523\/JNEUROSCI.20-09-03415.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T13:14:57Z","timestamp":1681391697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jneurosci.org\/lookup\/doi\/10.1523\/JNEUROSCI.20-09-03415.2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,1]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2000,5,1]]},"published-print":{"date-parts":[[2000,5,1]]}},"alternative-id":["10.1523\/JNEUROSCI.20-09-03415.2000"],"URL":"https:\/\/doi.org\/10.1523\/jneurosci.20-09-03415.2000","relation":{},"ISSN":["0270-6474","1529-2401"],"issn-type":[{"value":"0270-6474","type":"print"},{"value":"1529-2401","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5,1]]}}}